These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3330777)

  • 1. c-K-ras mutations in human carcinomas occur preferentially in codon 12.
    Yanez L; Groffen J; Valenzuela DM
    Oncogene; 1987; 1(3):315-8. PubMed ID: 3330777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.
    Gallinger S; Vivona AA; Odze RD; Mitri A; O'Beirne CP; Berk TC; Bapat BV
    Oncogene; 1995 May; 10(9):1875-8. PubMed ID: 7753564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
    Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
    Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ras oncogene activation in human ovarian carcinoma.
    van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
    Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of the c-Ki-ras-2 proto-oncogene in human colorectal carcinoma.
    Halatsch ME; Hirsch-Ernst KI; Weinel RJ; Kahl GF
    Anticancer Res; 1998; 18(4A):2323-5. PubMed ID: 9703874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of K-ras mutations in lung carcinomas: relationship to prognosis.
    Keohavong P; DeMichele MA; Melacrinos AC; Landreneau RJ; Weyant RJ; Siegfried JM
    Clin Cancer Res; 1996 Feb; 2(2):411-8. PubMed ID: 9816185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
    Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
    Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.
    Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA
    Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential and novel activation of H-ras in human bladder carcinomas.
    Visvanathan KV; Pocock RD; Summerhayes IC
    Oncogene Res; 1988; 3(1):77-86. PubMed ID: 3144694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon carcinoma K-ras 2 oncogene of a familial polyposis coli patient.
    Yuasa Y; Oto M; Sato C; Miyaki M; Iwama T; Tonomura A; Namba M
    Jpn J Cancer Res; 1986 Sep; 77(9):901-7. PubMed ID: 3021699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of ras mutations in human lung cancer. Minireview.
    Vachtenheim J
    Neoplasma; 1997; 44(3):145-9. PubMed ID: 9372854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
    Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
    Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras oncogenes in human cancer: a review.
    Bos JL
    Cancer Res; 1989 Sep; 49(17):4682-9. PubMed ID: 2547513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
    Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
    Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ras mutations and expression in head and neck squamous cell carcinomas.
    Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
    Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.